Innovative trial designs to improving tuberculosis drug development

Journal of Infectious Diseases

Volumn 207, Issue 3, 2013, Pages 544-

  Dodd, Lori E ^a   Proschan, Michael A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; DRUG RESEARCH; HEALTH CARE NEED; HUMAN; LETTER; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; STUDY DESIGN; THERAPY EFFECT; TUBERCULOSIS; DRUG DEVELOPMENT; MEDICATION ERROR; MULTIARM MULTISTAGE DESIGN; PROGRAM EFFECTIVENESS; TOTAL QUALITY MANAGEMENT;

ANTITUBERCULAR AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; RESEARCH DESIGN; TUBERCULOSIS;

EID: 84872039593     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis704     Document Type: Letter

References (1)

1. Phillips PPJ, Gillespie SH, Boeree M, et al. Innovative trial designs are practical solutions for improving the treatment of tuberculosis. J Infect Dis 2012; (205 Suppl 2):S250-7.